Feature|Articles|November 15, 2024
- Pharmaceutical Executive: November 2024
- Volume 44
- Issue 11
Pharmaceutical Executive: November 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 1 year ago
AI’s Attention Spanover 1 year ago
Noam Solomon: Bringing the Human Story to AIover 1 year ago
ROI and Rare Disease: Retooling the ‘Gene’ Value Machineover 1 year ago
The Leap Forward: Practical Gains for Pharma AI Useover 1 year ago
Powering Pipelines Forward: Approach Science Differentlyover 1 year ago
Navigating the Current Landscape for Pharma Leadersover 1 year ago
Passage to Asia: Early Access for Innovative Therapiesover 1 year ago
Digital Protection: Q&A with Jeffrey BernsteinNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
3
Teva Enters $900 Million Agreement to Acquire Emalex
4
Pharmaceutical Risks in the Strait of Hormuz
5

